encyclopedia of medical concepts
ψ 
ψ 
ψ 
ψ 

Drug Screening Assays, Antitumor

More information in Books or onNLM PubMed
Definition: Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals.  IM when general; NIM when with specific antineoplastic agent (IM)   
Examples Tumor Stem Cell Assay
Other names Dye Exclusion Assays, Antitumor; Drug Screening Tests, Tumor-Specific; Cancer Drug Tests; Antitumor Drug Screens; Anticancer Drug Sensitivity Tests; Tumor Specific Drug Screening Tests; Tests, Cancer Drug; Test, Cancer Drug; Screens, Antitumor Drug; Screens, Anti-Cancer Drug; Screen, Antitumor Drug; Screen, Anti-Cancer Drug; Drug Tests, Cancer; Drug Test, Cancer; Drug Screens, Antitumor; Drug Screens, Anti-Cancer; Drug Screening Tests, Tumor Specific; Drug Screen, Antitumor; Drug Screen, Anti-Cancer; Cancer Drug Test

To share this definition, click "text" (Facebook, Twitter) or "link" (blog, mail) then paste text link
Ads by Google

Sources: NLM Medical Subject Headings, NIH UMLS, Drugs@FDA, FDA AERS original data copyright United States Government. No endorsement implied. Last modified 6/6/2012

Warning: the drugs or drug combinations referred to here may be similar or related, but are not be the same ones and may not have the same pharmacological action as other substances described on the same page or in the same row. Please refer to product monograph or to your doctor
This website is accredited by Health On the Net Foundation. Click to verify.
We comply with the HONcode standard for trustworthy health information: verify here.
About Reference.MD Privacy